<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink">
    <mets:dmdSec ID="DMD_33235720-ab11-435c-9707-359672486416">
        <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
            <mets:xmlData>
                <mods xmlns="http://www.loc.gov/mods/v3" version="3.7" xmlns:vl="http://visuallibrary.net/vl">
                    <titleInfo lang="eng">
                        <title>Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma</title>
                    </titleInfo>
                    <name type="personal">
                        <displayForm>Flammang, Isabelle</displayForm>
                        <namePart type="given">Isabelle</namePart>
                        <namePart type="family">Flammang</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal" authority="gnd" authorityURI="http://d-nb.info/gnd/" valueURI="http://d-nb.info/gnd/1240726937">
                        <displayForm>Reese, Moritz</displayForm>
                        <namePart type="given">Moritz</namePart>
                        <namePart type="family">Reese</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal" authority="gnd" authorityURI="http://d-nb.info/gnd/" valueURI="http://d-nb.info/gnd/1197655980">
                        <displayForm>Yang, Zixuan</displayForm>
                        <namePart type="given">Zixuan</namePart>
                        <namePart type="family">Yang</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal" authority="gnd" authorityURI="http://d-nb.info/gnd/" valueURI="http://d-nb.info/gnd/173160328">
                        <displayForm>Eble, Johannes A.</displayForm>
                        <namePart type="given">Johannes A.</namePart>
                        <namePart type="family">Eble</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal" authority="gnd" authorityURI="http://d-nb.info/gnd/" valueURI="http://d-nb.info/gnd/130109711">
                        <displayForm>Dhayat, Sameer</displayForm>
                        <namePart type="given">Sameer</namePart>
                        <namePart type="family">Dhayat</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <typeOfResource>text</typeOfResource>
                    <genre authority="dini">article</genre>
                    <originInfo>
                        <dateIssued encoding="w3cdtf" keyDate="yes">2020-06-25</dateIssued>
                        <dateIssued encoding="w3cdtf">2022-03-31</dateIssued>
                    </originInfo>
                    <language>
                        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
                    </language>
                    <abstract lang="eng">Pancreatic ductal adenocarcinoma (PDAC) is characterized by fast tumor progression and diagnosis at advanced, inoperable stages. Previous studies could demonstrate an involvement of miR-192-5p in epigenetic regulation of visceral carcinomas. Due to contradictory results, however, the clinical utility of miR-192-5p in PDAC has yet to be determined. MiR-192-5p expression was analyzed by RT-qRT-PCR in human PDAC and benign tissue (n = 78), blood serum (n = 81) and serum exosomes (n = 74), as well as in PDAC cell lines (n = 5), chemoresistant cell clones (n = 2), and pancreatic duct cell line H6c7. Analysis of EMT-associated (epithelial-to-mesenchymal transition) proteins was performed by immunohistochemistry and Western blot. MiR-192-5p was deregulated in PDAC as compared to healthy controls (HCs), with downregulation in macrodissected tissue (p &lt; 0.001) and upregulation in blood serum of PDAC UICC (Union for International Cancer Control) stage IV (p = 0.016) and serum exosomes of PDAC UICC stages II to IV (p &lt; 0.001). MiR-192-5p expression in tumor tissue was significantly lower as compared to corresponding peritumoral tissue (PDAC UICC stage II: p &lt; 0.001; PDAC UICC stage III: p = 0.024), while EMT markers ZEB1 and ZEB2 were more frequently expressed in tumor tissue as compared to peritumoral tissue, HCs, and chronic pancreatitis. Tissue-derived (AUC of 0.86; p &lt; 0.0001) and exosomal (AUC of 0.83; p = 0.0004) miR-192-5p could differentiate between PDAC and HCs with good accuracy. Furthermore, high expression of miR-192-5p in PDAC tissue of curatively resected PDAC patients correlated with prolonged overall and recurrence-free survival in multivariate analysis. In vitro, miR-192-5p was downregulated in gemcitabine-resistant cell clones of AsPC-1 (p = 0.029). Transient transfection of MIA PaCa-2 cells with miR-192-5p mimic resulted in downregulation of ZEB2. MiR-192-5p seems to possess a tumor-suppressive role and high potential as a diagnostic and prognostic marker in PDAC.</abstract>
                    <note type="citation/reference">Cancers 12 (2020) 6, 1693, 1-19</note>
                    <note>Finanziert durch den Open-Access-Publikationsfonds der Westf채lischen Wilhelms-Universit채t M체nster (WWU M체nster).</note>
                    <subject lang="eng">
                        <topic>pancreatic ductal adenocarcinoma</topic>
                        <topic>microRNA-192-5p</topic>
                        <topic>epithelial-to-mesenchymal transition</topic>
                        <topic>liquid biopsy</topic>
                        <topic>exosomes</topic>
                        <topic>zinc finger E-box-binding homeobox 2</topic>
                    </subject>
                    <classification authority="ddc">610</classification>
                    <identifier type="urn">urn:nbn:de:hbz:6-64049491136</identifier>
                    <identifier type="doi">10.17879/64049492764</identifier>
                    <accessCondition type="use and reproduction" xlink:href="http://creativecommons.org/licenses/by/4.0/">CC BY 4.0</accessCondition>
                    <recordInfo>
                        <recordIdentifier>muenster_miami_33235720-ab11-435c-9707-359672486416</recordIdentifier>
                    </recordInfo>
                    <extension>
                        <vl:doctype>oaArticle</vl:doctype>
                    </extension>
                </mods>
            </mets:xmlData>
        </mets:mdWrap>
    </mets:dmdSec>
    <mets:fileSec>
        <mets:fileGrp USE="pdf upload">
            <mets:file MIMETYPE="application/pdf" ID="FILE_33235720-ab11-435c-9707-359672486416_1">
                <mets:FLocat xlink:href="https://repositorium.uni-muenster.de/document/miami/33235720-ab11-435c-9707-359672486416/10.3390_cancers12061693.pdf" LOCTYPE="URL"/>
            </mets:file>
        </mets:fileGrp>
    </mets:fileSec>
    <mets:structMap TYPE="LOGICAL">
        <mets:div TYPE="document" ID="muenster_miami_33235720-ab11-435c-9707-359672486416" DMDID="DMD_33235720-ab11-435c-9707-359672486416">
            <mets:fptr FILEID="FILE_33235720-ab11-435c-9707-359672486416_1"/>
        </mets:div>
    </mets:structMap>
</mets:mets>
